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Abstract: 
Background:  Current guidelines recommend screening colonoscopy at 10 year intervals in 
average risk individuals who had baseline screening colonoscopy (no polyps or only hyperplastic 
polyps ≤ 5 mm in the recto-sigmoid colon), but the yield of repeat screening at 10 years is 
unknown. 
Aim: Describe the yield of second screening colonoscopy in average risk individuals performed 
at least 8 years after a first screening colonoscopy had shown no polyps or only distal 
hyperplastic polyps ≤ 5 mm in size. 
Methods: Review of a database for colonoscopies performed at Indiana University Hospital 
between January 1999 and November 2015. 
Results: A total of 4,463 individuals underwent screening colonoscopy between January 1999 
and July 2007, of which, 1,566 individuals had no polyps and 334 individuals had only distal 
hyperplastic polyps ≤ 5 mm; 378 individuals (58.4% female) had follow up screening at least 8 
years after the baseline screening exam with a mean interval of 9.74 (+/- 1.2) years (range 8 to 15 
years). Mean age at baseline screening exam was 56.7 (+/- 5.5) years and at follow-up screening 
exam was 66.4 (+/- 5.6) years. At the second screen there were 224 patients (59.3%) with at least 
1 polyp, including 144 (38.1%) with at least 1 conventional adenoma. The adenoma detection 
rate (ADR) at the second screen exam was 36.1% and 56.8% in the groups with no polyp at 
baseline and with only distal hyperplastic polyps respectively. There were 15 advanced 
neoplasms in 13 individuals (3.4%), of which 12 lesions were proximal to the sigmoid colon. 
There were no cancers at follow-up. 
Conclusion:  Among individuals age ≥ 50 years with normal baseline screening colonoscopies, 
the incidence of advanced lesions at a second screening colonoscopy at least 8 years later was 
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comparable to that in baseline screening studies.  Our findings support current recommendations 
for screening at 10 year intervals in average risk individuals. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 
 
Introduction: 
Screening colonoscopy is recommended in all guidelines at 10-year intervals in average risk 
subjects 1-3.  Previous reports have described the yield of a second colonoscopy 5 years after an 
initial negative examination in average risk persons 4,5.  The yield for advanced adenomas at 5 
years is low, supporting an interval longer than 5 years 5.  Case-control studies suggest that 
patients are protected for 20 years or longer after a negative colonoscopy 6.  A negative 
colonoscopy may be the single strongest predictor of protection from colorectal cancer. 
 
In this report, we describe the yield of a second screening colonoscopy in 378 average risk 
persons. All of the study subjects had either no polyps or only distal (recto-sigmoid colon) 
hyperplastic polyps ≤ 5mm in size at an initial screening examination at age 50 or older. All 
returned in routine clinical practice at least 8 years later for a second examination while still 
asymptomatic.  
 
Materials and Methods 
 
We reviewed a prospectively maintained quality database for colonoscopies at Indiana 
University Hospital and its affiliated outpatient endoscopy units since 1999.  Permission to 
review the database was granted by the Institutional Review Board at Indiana University Health 
on September 29, 2015.  Eligible subjects were at least 50 years of age at their baseline 
examination, had no personal or family history of colorectal cancer, no personal history of 
colorectal polyps, no history of inflammatory bowel disease, and were asymptomatic. All had 
"screening" listed as their indication for both the initial and second examination, and  had no 
5 
 
colorectal polyps or only distal colon hyperplastic polyps ≤ 5 mm in size identified during the 
baseline colonoscopy. Subjects had a complete examination to the cecum with the bowel 
preparation listed as adequate, good or excellent.   
 
Subjects underwent their initial screening examination between January 1999 and July 2007 and 
the follow up screening examination between January 2007 and November 2015.  All 
examinations were performed by attending gastroenterologists.  A total of 23 attending 
gastroenterologists performed the follow-up examinations.  Gastroenterology fellows 
participated in some examinations, but withdrawals were supervised in all cases by attendings. 
 
Conventional adenomas included tubular, tubulovillous and villous adenomas, and were 
characterized as having low-grade or high-grade dysplasia. Advanced conventional adenomas 
were those with villous elements, high-grade dysplasia, or size ≥ 10 mm. Serrated class lesions 
included hyperplastic polyps and sessile serrated polyps (SSP; synonymous with sessile serrated 
adenoma).  Advanced conventional adenomas and SSPs ≥ 10 mm in size or with cytological 
dysplasia were considered advanced neoplasms. 
 
The chi-square test was used to compare gender, incidence of any polyp, adenoma, adenomas in 
males, and adenomas in females between the groups without and with distal colon hyperplastic 
polyps at baseline colonoscopy. The two-sample t-test was used to compare age and interval 
between examinations and Fishers Exact test was used to compare the incidence of any advanced 
adenomas between these groups. 
Results 
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A total of 4,463 subjects underwent screening colonoscopy between January 1999 and July 2007, 
of which, 1,566 (35.1%) subjects had no colorectal polyps and 334 (7.5%) subjects had only 
distal colon (rectum and/or sigmoid) hyperplastic polyps ≤ 5 mm. There were 341 subjects with 
no colorectal polyps and 37 who had only distal diminutive colorectal polyps at baseline who 
had follow up screening colonoscopy at our institution at least 8 years after baseline screening.  
The subjects who repeated a screening colonoscopy included 221 women who had mean age 
57.3 (+/- 5.5) years at the baseline examination, and 157 men with mean age 55.5 (+/- 5.7) years 
(Table 1). The overall mean age was 56.7 (+/- 5.5) years (range 50-71 years) at the baseline 
examination.  
 
At the second examination, the mean age was 66.4 (+/- 5.6) years (range 58-81 years).  The 
mean interval between examinations was 9.74 (+/- 1.2) years (range 8.0-15.0 years).  Additional 
demographic data on the study population is not available from the database.  Among those who 
completed second screening colonoscopies, 74 subjects had follow-up at 8 years, 52 subjects at 9 
years, 188 subjects at 10 years, 36 subjects at 11 years, and 28 subjects at 12 to 15 years. (Table 
2). 
 
 The adenoma detection rate (ADR) at the second screening examination was 36.1% in subjects 
with no baseline polyps and was higher at 56.8% in subjects with distal colon hyperplastic 
polyps at the baseline examination (p = .014), and the difference in ADR reached significance in 
women but was only a trend in men (Table 1).  At the second screening examination, a total of 
268 conventional adenomas (adenomas per colonoscopy or APC of 0.78) were detected in 
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subjects with no polyps at baseline and 37 conventional adenomas (APC 1.0) in subjects with 
hyperplastic polyps at baseline (Table 1).   The incidence of advanced neoplasms overall was 
3.4%, including 3.2% in the group with no polyps at baseline and 5.4% in the group with only 
hyperplastic polyps at baseline (p = 0.37).  
 
 Among the 252 patients with at least 10 years between examinations, the ADR was 39.6%, APC 
was 0.87, and the rate of advanced neoplasms was 3.6%. 
 
There were 13 individuals (8 females) with 15 advanced neoplasms at the second examination, 
of which 12 were proximal to the sigmoid (Table3). Nine patients had only advanced 
conventional adenomas, 3 had only advanced serrated class lesions, and one had both.  All 
polyps detected at the second examination were successfully resected endoscopically. 
 
Discussion 
 
In this study, we report our initial experience with performing screening colonoscopies at least 8 
years after an initial negative examination in average-risk persons.  The overall adenoma 
detection rate (ADR) at the second examination was substantial at 38.1%, which may partly 
reflect the mean age at the second examination of 66 years in these groups, which is higher than 
the mean age of essentially all previous screening colonoscopy studies examining the yield of the 
first time examinations in average-risk persons 7-10.  The high ADR may also reflect improved 
methods of bowel preparation, improved colonoscope imaging, and improved awareness of the 
importance of ADR since the baseline examination were performed.  In any case, none of these 
8 
 
asymptomatic individuals had cancer, and the yield of advanced lesions was 3.4%, which is 
comparable to the rate of first time screening examinations 7-10.  
 
Our study has several limitations.  First, patients were not systematically referred for a second 
examination.  Thus, the subjects who presented for a second examination may have had a greater 
interest in maintaining good health behaviors than the general population, which might lower 
their risk of incident neoplasia. Next, patients who had a second colonoscopy for symptoms 
before a 10 year screening was due were not included. We arbitrarily included patients with an 
interval between examinations of >8 and < 10 years, since our experience is that a significant 
number of patients who were instructed to wait 10 years actually present a year or two early, 
perhaps because of their own or their physician’s concerns about waiting until 10 years, or 
perhaps in some instances they lost track of the interval.  Our system is open access, and we did 
not block these patients from undergoing the second screen early. We included these patients in 
this report because we suspect other’s experience is similar to ours, and because the yield of a 
second screen in the 8-10 year interval has not been previously described.  Our results generally 
support encouraging asymptomatic patients to wait the full 10 years between examinations. 
 
Our data support a screening interval for average risk individuals of at least 10 years in patients 
with high quality baseline examinations 2.   The high overall ADR of 38.1% should not be 
considered a rationale to perform screening earlier than 10 years, since the overwhelming 
majority of lesions detected were diminutive and non-advanced lesions with a very low potential 
for harm.  Additional data are needed to know whether longer intervals than 10 years are 
appropriate for selected portions of the average risk population, such as nonsmokers or persons 
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examined by colonoscopists with high adenoma detection rates.  Our data suggest the ADR 
targets used for first-time screening colonoscopies may be appropriate for second examinations 
also. Also, because 80% of the advanced lesions detected at the second screen were proximal to 
the sigmoid colon, our results support using colonoscopy rather than sigmoidoscopy for the 
second screening. 
 
In summary, this is the first report of the yield of a second screening examination approximately 
10 years after an initial negative examination in average-risk persons.  We expect this result will 
stimulate others to examine their experience in this regard, and a larger experience will provide 
an accurate picture of the yield of a second examination, and whether subsets of individuals with 
an initial negative examination can undergo a second screening colonoscopy at an interval longer 
than 10 years.  
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Table 1: Demographics, yield and polyp histology at second screening 
  
Subjects without 
polyps at baseline 
exam 
Subjects with 
distal 
hyperplastic 
polyps at 
baseline exam 
p-value 
 Number Number  
Male 143 (41.9%) 14 (37.8%) 
Female 198 (58.1%) 23 (62.2%) 
Mean age at second screening colonoscopy (range) 66.4 (58-81) 66.4 (58-81) 0.97 
Mean interval years (range) 9.8 (8-15) 9.7 (8-13) 0.89 
Yield at second screening colonoscopy      
Patients with ≥ 1 polyp 189 (55.4% ) 35 (94.5%) 0.001 
Patients with ≥ 1 conventional adenoma 123 (36.1%) 21 (56.8%) 0.014 
Males with ≥ 1 conventional adenoma (ADR)  55 (38.5%) 8 (57.1%) 0.17 
Females with ≥ 1 conventional adenoma (ADR) 68 (34.3%) 13 (56.5%) 0.037 
Patients with ≥ 1 advanced neoplasm 11 (3.2%) 2 (5.4%) 0.37 
Histology of lesions at second examination      
Tubular adenoma 263 (57.4%) 37 (44.0%)  
Tubulovillous adenoma 5 (1.1%) 0   
Hyperplastic polyp 110 (24.0%) 36 (42.9%)  
Benign mucosa 71 (15.5%) 10 (11.9%)  
Sessile serrated polyp 7 (1.5%) 1 (1.2%)  
Inflammatory polyp 2 (0.4%) 0  
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Table 2: Number of subjects and interval between initial and second screening colonoscopies 
  
Interval between screens 
(years) 
Subjects without 
polyps at baseline 
exam 
Subjects with distal 
hyperplastic polyps at baseline 
exam 
8 67 7 
9 43 9 
10 174 14 
11 33 3 
12 13 2 
13 8 2 
14 2 0 
15 1 0 
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Table 3.   Findings in 13 patients with advanced neoplasms at the second screening examinations 
 
Patient Finding 
1 
2mm and 6 mm tubulovillous adenomas in rectum and transverse colon 
respectively 
2 5 mm tubulovillous adenoma in cecum     
3 6 mm tubular adenoma in sigmoid colon; high grade dysplasia 
4 10 mm tubular adenoma in hepatic flexure 
5 10 mm tubular adenoma in transverse colon 
6 12 mm tubular adenoma in transverse colon 
7 25 mm tubulovillous adenoma at ileo-cecal valve 
8 25 tubulovillous adenoma in rectum 
9 35 mm tubulovillous adenoma in ascending colon; high grade dysplasia 
10 10 mm sessile serrated polyp in ascending colon, 12 mm tubular adenoma in ascending colon                    
11 12 mm sessile serrated polyp in ascending colon 
12 12 mm sessile serrated polyp in transverse colon 
13 30 mm sessile serrated polyp in ascending colon 
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